Jonnathan Marcelo Chiliquinga Chaca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jonnathan Marcelo Chiliquinga Chaca has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ambar Karolina Cedeño Cedeño
Universidad Católica de Santiago de Guayaquil
1 shared publication - Carlos Rojas
Department of Health Rehabilitation Sciences, University of Bío-Bío, Chillán 3780000, Chile
1 shared publication - Christian Paúl Rodas Cabrera
Universidad del Azuay
1 shared publication - Dariana Jiménez Báez
Benemérita Universidad Autónoma de Puebla
1 shared publication - Diana Isabel Escobar Alzate
Pontificia Universidad Javeriana Cali
1 shared publication - Héctor de la Torre Hasbum
Universidad del Magdalena
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 5 (2)
Beyond the Operating Room: Preventing Elective Surgical Cancellations Through Preoperative Optimization and Integrated Healthcare Management
Avoidable elective surgical cancellations represent a persistent challenge for healthcare systems, affecting patient safety, continuity of care, operating room efficiency, and institutional resource utilization. This narrative review aimed to analyze the clinical, organizational, and administrative factors associated with surgical cancellations and examine preventive strategies involving preoperative assessment, individualized clinical optimization, and multidisciplinary healthcare management. International and Latin American scientific literature was critically synthesized using a structured analytical approach supported by the Define–Measure–Analyze–Improve–Control (DMAIC) framework. The reviewed evidence demonstrated considerable variability in reported cancellation frequencies, ranging from 2.7% to 19.91% among selected institutional investigations, while international meta-analyses reported pooled estimates of 14%–18%. Administrative and structural factors, insufficient preoperative preparation, unstable medical conditions, and patient-related circumstances emerged as important contributors. Structured preoperative assessment was consistently associated with lower cancellation frequencies in several observational studies, with reported differences depending on institutional characteristics and assessment modalities. Multidisciplinary interventions were also associated with reductions in selected preventable cancellation outcomes, although findings varied according to study design and analytical approach. Evidence from Mexico, Colombia, and Brazil highlighted the importance of considering regional healthcare infrastructure and organizational constraints. The review identified methodological heterogeneity, inconsistent definitions of preventability, and limited prospective evidence as important restrictions on direct comparisons and causal interpretation. Integrating anesthesiology, internal medicine, and healthcare administration within coordinated perioperative pathways may support the identification of modifiable risk factors, improved surgical scheduling, and more efficient resource allocation. Nevertheless, prevention strategies must distinguish avoidable disruptions from clinically justified postponements. Sustainable improvement requires standardized performance indicators, interdisciplinary collaboration, and continuous quality monitoring, with patient safety remaining the primary consideration in surgical decision-making.
- 30 June 2026
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 5 (2)
Open AccessBeyond the Operating Room: Preventing Elective Surgical Cancellations Through Preoperative Optimization and Integrated Healthcare Management
Avoidable elective surgical cancellations represent a persistent challenge for healthcare systems, affecting patient safety, continuity of care, operating room efficiency, and institutional resource utilization. This narrative review aimed to analyze the clinical, organizational, and administrative factors associated with surgical cancellations and examine preventive strategies involving preoperative assessment, individualized clinical optimization, and multidisciplinary healthcare management. International and Latin American scientific literature was critically synthesized using a structured analytical approach supported by the Define–Measure–Analyze–Improve–Control (DMAIC) framework. The reviewed evidence demonstrated considerable variability in reported cancellation frequencies, ranging from 2.7% to 19.91% among selected institutional investigations, while international meta-analyses reported pooled estimates of 14%–18%. Administrative and structural factors, insufficient preoperative preparation, unstable medical conditions, and patient-related circumstances emerged as important contributors. Structured preoperative assessment was consistently associated with lower cancellation frequencies in several observational studies, with reported differences depending on institutional characteristics and assessment modalities. Multidisciplinary interventions were also associated with reductions in selected preventable cancellation outcomes, although findings varied according to study design and analytical approach. Evidence from Mexico, Colombia, and Brazil highlighted the importance of considering regional healthcare infrastructure and organizational constraints. The review identified methodological heterogeneity, inconsistent definitions of preventability, and limited prospective evidence as important restrictions on direct comparisons and causal interpretation. Integrating anesthesiology, internal medicine, and healthcare administration within coordinated perioperative pathways may support the identification of modifiable risk factors, improved surgical scheduling, and more efficient resource allocation. Nevertheless, prevention strategies must distinguish avoidable disruptions from clinically justified postponements. Sustainable improvement requires standardized performance indicators, interdisciplinary collaboration, and continuous quality monitoring, with patient safety remaining the primary consideration in surgical decision-making.
- Open Access
- 30 June 2026
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 5 (2)
Beyond Chronological Age: Integrating Geriatric Assessment, Surgical Decision-Making, and Personalized Oncological Treatment in Glioblastoma
Glioblastoma represents one of the most aggressive primary malignant tumors of the central nervous system, presenting substantial therapeutic challenges in older adults due to the interaction between tumor progression, physiological vulnerability, comorbidities, and functional deterioration. This narrative review aimed to analyze the role of comprehensive geriatric assessment, extent of surgical resection, and individualized oncological strategies in patients aged 65 years and older. A structured descriptive and comparative analysis was conducted using 20 scientific publications, including randomized clinical trials, observational studies, meta-analyses, and international clinical recommendations, with particular consideration of Latin American contributions. The reviewed evidence indicated that surgical resection was associated with improved overall survival compared with biopsy, with a pooled mean difference of 6.13 months, although postoperative complications were more frequent following resection. Hypofractionated radiotherapy demonstrated clinically relevant survival outcomes in older populations, while the addition of temozolomide to short-course radiotherapy increased median overall survival from 7.6 to 9.3 months and progression-free survival from 3.9 to 5.3 months. MGMT promoter methylation emerged as an important predictive biomarker for chemotherapy benefit, supporting molecularly informed therapeutic selection. However, differences in frailty, cognitive function, neurological performance, and treatment tolerance remain essential considerations. The available evidence also revealed limitations regarding standardized geriatric assessment, postoperative functional outcomes, and the representation of Latin American populations in prospective research. Overall, individualized management integrating geriatric vulnerability, surgical feasibility, molecular characteristics, and patient-centered priorities provides a clinically relevant framework for therapeutic decision-making. Further prospective investigations are necessary to validate multidimensional treatment algorithms and improve survival while preserving neurological function, autonomy, and quality of life.
- 30 June 2026
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 5 (2)
Open AccessBeyond Chronological Age: Integrating Geriatric Assessment, Surgical Decision-Making, and Personalized Oncological Treatment in Glioblastoma
Glioblastoma represents one of the most aggressive primary malignant tumors of the central nervous system, presenting substantial therapeutic challenges in older adults due to the interaction between tumor progression, physiological vulnerability, comorbidities, and functional deterioration. This narrative review aimed to analyze the role of comprehensive geriatric assessment, extent of surgical resection, and individualized oncological strategies in patients aged 65 years and older. A structured descriptive and comparative analysis was conducted using 20 scientific publications, including randomized clinical trials, observational studies, meta-analyses, and international clinical recommendations, with particular consideration of Latin American contributions. The reviewed evidence indicated that surgical resection was associated with improved overall survival compared with biopsy, with a pooled mean difference of 6.13 months, although postoperative complications were more frequent following resection. Hypofractionated radiotherapy demonstrated clinically relevant survival outcomes in older populations, while the addition of temozolomide to short-course radiotherapy increased median overall survival from 7.6 to 9.3 months and progression-free survival from 3.9 to 5.3 months. MGMT promoter methylation emerged as an important predictive biomarker for chemotherapy benefit, supporting molecularly informed therapeutic selection. However, differences in frailty, cognitive function, neurological performance, and treatment tolerance remain essential considerations. The available evidence also revealed limitations regarding standardized geriatric assessment, postoperative functional outcomes, and the representation of Latin American populations in prospective research. Overall, individualized management integrating geriatric vulnerability, surgical feasibility, molecular characteristics, and patient-centered priorities provides a clinically relevant framework for therapeutic decision-making. Further prospective investigations are necessary to validate multidimensional treatment algorithms and improve survival while preserving neurological function, autonomy, and quality of life.